Curation SCA8 ATXN8OS
6 + 5.5 = 11.5 / 18
Genetic evidence
Total: 6
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | Large SCA8 cohort of 77 families including 199 expansion carriers (111 affected, 88 asymptomatic); 10 families showed autosomal-dominant inheritance and CCG•CGG interruptions were enriched in families with multiple affected individuals. |
Experimental evidence
Total: 5.5
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Biochemical function | 0.5 | ATXN8OS is transcribed through the SCA8 CTG repeat as a processed, untranslated CUG-containing RNA; brain/cerebellar expression supports a locus-specific RNA function. | |
Function | Regulatory impact | 0.5 | Supports ATXN8OS transcription and possible antisense regulatory biology. | |
Function | Regulatory impact | 1.5 | Strand-specific RT-PCR/RACE showed the CTG repeat is in a spliced, polyadenylated ATXN8OS transcript expressed in brain and overlapping an opposite-strand transcript, supporting locus-specific regulatory impact. | |
Models | Non-human model organism | 2 | A transgenic SCA8 mouse model was created with the full-length human SCA8 (CTG)116 expansion transcribed under its endogenous promoter. The mice developed a progressive neurological phenotype and reduced cerebellar-cortical inhibition. | |
Models | Cell culture | 1 | Patient-derived repeat constructs in T98/HEK293T cells showed CCG•CGG interruptions increased cell toxicity, p-eIF2α activation, and polyAla/polySer RAN protein levels independent of RNA abundance. |